Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Respiratory Tract Infections: early-phase trial registry
4 of 16 indexed Respiratory Tract Infections trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,060 of 28,707 conditions by registered trial count.
16 US clinical trials · 4 currently recruiting · #1,060 of 28,707 conditions by registered trial count
Respiratory Tract Infections: 16 US clinical trials tracked, 4 recruiting.
Respiratory Tract Infections is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is HealthMode, running 1 of these trials.
Enrollment posture brief
Registry condition respiratory-tract-infections
OPEN 4 | RECR 25% | LATE 1 | EARLY 4 | RANK #1060 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Respiratory Tract Infections lists 4 open slots (25% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Respiratory Tract Infections on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Respiratory Tract Infections is recruiting below its size-band peers.
4 of 16 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Respiratory Tract Infections trials is spread across many organizations.
HealthMode accounts for 1 of 16 trials (6.3%). 16 distinct sponsors appear on at least one study for this condition label.
-
Typical Respiratory Tract Infections enrolment sits around 324 participants.
Median target enrolment is 324 among the 16 trials that report a genuine target (sentinel values excluded). 3 of those (18.8%) plan for fewer than 100 participants.
-
Respiratory Tract Infections research is mostly interventional.
12 interventional and 4 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
16 total, page 1 of 1
Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses
University of Nebraska
NCT05864118
Beetroot Juice NO Cold Study
Southern Methodist University
NCT06416228
An Adjunct Test Distinguishing Bacterial From Viral Etiology Improves Resource Utilization and Efficiency in the ED.
The University of Texas Health Science Center, Houston
NCT06070688
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
Geisinger Clinic
NCT06495021
Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
Restorbio
NCT03373903
Patient Portal Flu Vaccine Reminders (RCT 6)
University of California, Los Angeles
NCT06062264
Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults
Medicago
NCT03301051
Home Testing of Respiratory Illness
Evidation Health
NCT04245800
Vitamin D3 Supplementation to Prevent Respiratory Tract Infections
The Cooper Health System
NCT04596657
Audio Data Collection for Identification and Classification of Coughing
HealthMode
NCT04326309
Hand Hygiene Randomized Cluster Intervention to Reduce Infections
Kent State University
NCT02131727
Rapid Detection of Airway Pathogens for Lung Transplantation
University of California, San Francisco
NCT03933878
Measuring the Influence of Kefir on Children's Stools on Antibiotics (MILK)
Georgetown University
NCT00481507
Effect of Honey and Dextromethorphan on Nocturnal Cough and Sleep
Penn State University
NCT00127686
A Study to Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age
Janssen Vaccines & Prevention B.V.
NCT03303625
A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness
Duke University
NCT03741322
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Respiratory Tract Infections records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Respiratory Tract Infections trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Respiratory Tract Infections page
16 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Respiratory Tract Infections trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- HealthMode sponsors the most Respiratory Tract Infections trials on record, review their full trial history before evaluating a specific study. See HealthMode's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Respiratory Tract Infections condition card totals 16 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.